Condition
Hypertrophic Cardiomyopathies
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07428031Not Yet Recruiting
French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
NCT06859827Active Not RecruitingPrimary
Role of CMR-FT in Assessment of HCM and Athlete's Heart.
NCT06730464Recruiting
Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy
NCT02187263Unknown
German Centre for Cardiovascular Research Cardiomyopathy Register
Showing all 4 trials